Background At global level, there are 37 million people infected with HIV and 115 million
people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV …

Background Morbidity associated with HIV infection is poorly characterised, so we aimed to
investigate the contribution of different comorbidities to hospital admission and in-hospital …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Abstract Background Hepatitis C (HCV) can only be eradicated if annual rates of cure (SVR)
are consistently and significantly higher than new HCV infections, across many countries. In …

Objective Better knowledge of hepatitis B virus (HBV) infection prevalence at the national
level can help to implement pertinent strategies to address HBV related burden. The aim …

In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030. Africa, and
more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of …

Future directions and innovations in hepatitis testing include strategies to improve access
such as through use of existing facility and community-based testing opportunities for …

Background & Aims The fixed-dose combination of sofosbuvir/velpatasvir was highly
efficacious in patients infected with genotype (GT) 1–6 hepatitis C virus (HCV) in the …

Objective To estimate population-wide hepatitis B and C seroprevalence using dried blood
spot samples acquired for human immunodeficiency virus (HIV) surveillance as part of the …